Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00882492 · ClinicalTrials.gov registry record · Phase 1

GLP 1 for Intraoperative Glycemic Control

A Phase 1 study of Hypoglycemia and Hyperglycemia, sponsored by University of Pennsylvania.

Completed
Registry status
Phase 1
Development phase
80
Enrollment target
1
Study location

NCT00882492 is a Phase 1 study of Hypoglycemia and Hyperglycemia that has completed, run by University of Pennsylvania. The registered enrollment target is 80 participants, below the 505-participant average among 40 other Hypoglycemia trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00882492, a Phase 1 study of Hypoglycemia and Hyperglycemia, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
Phase 1
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This is a medical research study designed to see if an infusion of a naturally occurring hormone, GLP-1, works when used to decrease blood sugar during cardiac surgery.

Interventions

  • BIOLOGICAL GLP 1
  • BIOLOGICAL normal saline solution placebo

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2008-12
Est. Completion 2011-05
Phase Phase 1

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT00882492

The ClinicalTrials.gov registry entry for NCT00882492 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 505-participant average among 40 other Hypoglycemia trials with a reported enrollment target (84% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypoglycemia appearing as the primary indexed condition, and to 2 interventions - of which GLP 1 is the first listed.

NCT00882492 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00882492 about?

NCT00882492 is a clinical study titled "GLP 1 for Intraoperative Glycemic Control". This is a medical research study designed to see if an infusion of a naturally occurring hormone, GLP-1, works when used to decrease blood sugar during cardiac surgery.

What is the current status of trial NCT00882492?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2008-12. Estimated completion is 2011-05.

What conditions does trial NCT00882492 study?

This clinical trial studies the following conditions: Hypoglycemia, Hyperglycemia.

What interventions are being tested in trial NCT00882492?

The interventions under investigation include: GLP 1 (BIOLOGICAL), normal saline solution placebo (BIOLOGICAL).

Who is sponsoring clinical trial NCT00882492?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00882492 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoglycemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.